Showing 1 - 10 of 16
The support for scientific investigation in biomedicine depends in part on the adoption of new knowledge into medical practice. We investigate how a technological advance, in the form of a large and influential 2010 randomized controlled study, changed physician practice in statin (a medication...
Persistent link: https://www.econbiz.de/10012480146
Persistent link: https://www.econbiz.de/10012112734
The support for scientific investigation in biomedicine depends in part on the adoption of new knowledge into medical practice. We investigate how a technological advance, in the form of a large and influential 2010 randomized controlled study, changed physician practice in statin (a medication...
Persistent link: https://www.econbiz.de/10012863696
Persistent link: https://www.econbiz.de/10011797732
Persistent link: https://www.econbiz.de/10003768821
Persistent link: https://www.econbiz.de/10011483656
Persistent link: https://www.econbiz.de/10001666580
Persistent link: https://www.econbiz.de/10001240393
Throughout history, technological progress has transformed population health, but the distributional effects of these gains are unclear. New substitutes for older, more expensive health technologies can produce convergence in population health outcomes, but may also be prone to “elite...
Persistent link: https://www.econbiz.de/10012893126
This paper contributes to the literature on the role of technology shocks as source of the business cycle in two ways. First, we document that time-series of US productivity and hours are apparently affected by a structural break in the late 60's, which is likely due to a major change in the...
Persistent link: https://www.econbiz.de/10012709026